Analysis for Agilent Technologies

Description & usage

Agilent Technologies develops analytical instruments, lab solutions, and diagnostic technologies for research, pharma, and industrial customers. The company benefits from high technical barriers and recurring revenue from consumables and services. Key drivers are order momentum, product innovation, service mix, and margin strength.

Basic info

Symbol: A
Category: Health Care
Available history: 1.0 years
Last trading day: 06/04/2026

Market context

DXY: 120.89last available value
US 10Y Real: 1.99%
Fed Balance: $6.68T
CPI YoY: 2.4%
Fed Rate: 3.75%
US 10Y: 4.35%

VIX: 24.54
HY OAS: 3.17%
Brent: $121.88
Core CPI: 2.5%
US 2Y: 3.84%
ISM PMI: –

Score overview

Analysis summary

Overall, the technical picture is still weak and under pressure. Stability is currently doing more of the work than performance, with sub-scores of 4 for performance, 52 for stability and 27 for trend.

There is little technical support visible in this weaker setup. The current drawdown sits around 90.6 %, so the damage is still a central part of the read rather than a stabilizing feature.

The clearest drag is that price is still below important moving averages. It sits at -16.5 % versus SMA50 and -38.3 % versus SMA200, which points to ongoing technical pressure.

The next key change would be a recovery back above the main moving averages. That would suggest the technical pressure is easing rather than merely slowing.

Historical evaluation and qualitative market context only, not investment advice.